Ensign Group Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Ensign Group has been growing earnings at an average annual rate of 16%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 15% per year. Ensign Group's return on equity is 13.7%, and it has net margins of 5.8%.
Belangrijke informatie
16.0%
Groei van de winst
15.0%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 15.0% |
| Rendement op eigen vermogen | 13.7% |
| Nettomarge | 5.8% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
The Ensign Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Oct 27
The Ensign Group, Inc.'s (NASDAQ:ENSG) P/E Still Appears To Be Reasonable
Sep 27Is Now An Opportune Moment To Examine The Ensign Group, Inc. (NASDAQ:ENSG)?
Sep 09Does Ensign Group (NASDAQ:ENSG) Have A Healthy Balance Sheet?
Jul 29Getting In Cheap On The Ensign Group, Inc. (NASDAQ:ENSG) Might Be Difficult
Jun 18Ensign Group: Priced On Asset Growth, Supported By Fundamentals
Jun 12What Is The Ensign Group, Inc.'s (NASDAQ:ENSG) Share Price Doing?
May 30Shareholders Will Most Likely Find The Ensign Group, Inc.'s (NASDAQ:ENSG) CEO Compensation Acceptable
May 10Earnings Update: The Ensign Group, Inc. (NASDAQ:ENSG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
May 05Is There An Opportunity With The Ensign Group, Inc.'s (NASDAQ:ENSG) 37% Undervaluation?
Apr 17Ensign Group (NASDAQ:ENSG) Seems To Use Debt Quite Sensibly
Mar 11The Ensign Group, Inc.'s (NASDAQ:ENSG) Popularity With Investors Is Clear
Feb 22Is It Time To Consider Buying The Ensign Group, Inc. (NASDAQ:ENSG)?
Jan 15A Look At The Fair Value Of The Ensign Group, Inc. (NASDAQ:ENSG)
Dec 30Here's Why We Think Ensign Group (NASDAQ:ENSG) Is Well Worth Watching
Dec 15We Think Ensign Group (NASDAQ:ENSG) Can Stay On Top Of Its Debt
Nov 13Is Now An Opportune Moment To Examine The Ensign Group, Inc. (NASDAQ:ENSG)?
Oct 13Estimating The Fair Value Of The Ensign Group, Inc. (NASDAQ:ENSG)
Sep 28Here's Why We Think Ensign Group (NASDAQ:ENSG) Is Well Worth Watching
Sep 06Is Ensign Group (NASDAQ:ENSG) A Risky Investment?
Aug 04Why The Ensign Group, Inc. (NASDAQ:ENSG) Could Be Worth Watching
Jul 04Calculating The Intrinsic Value Of The Ensign Group, Inc. (NASDAQ:ENSG)
Jun 19With EPS Growth And More, Ensign Group (NASDAQ:ENSG) Makes An Interesting Case
Jun 03Is Ensign Group (NASDAQ:ENSG) A Risky Investment?
May 02At US$91.91, Is The Ensign Group, Inc. (NASDAQ:ENSG) Worth Looking At Closely?
Mar 29Calculating The Intrinsic Value Of The Ensign Group, Inc. (NASDAQ:ENSG)
Mar 14With EPS Growth And More, Ensign Group (NASDAQ:ENSG) Makes An Interesting Case
Feb 27Here's Why Ensign Group (NASDAQ:ENSG) Can Manage Its Debt Responsibly
Jan 27At US$95.26, Is The Ensign Group, Inc. (NASDAQ:ENSG) Worth Looking At Closely?
Dec 28Opbrengsten en kosten
Hoe Ensign Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 4,109 | 240 | 299 | 0 |
| 30 Jun 24 | 3,968 | 225 | 293 | 0 |
| 31 Mar 24 | 3,853 | 218 | 290 | 0 |
| 31 Dec 23 | 3,729 | 209 | 283 | 0 |
| 30 Sep 23 | 3,559 | 248 | 218 | 0 |
| 30 Jun 23 | 3,388 | 240 | 205 | 0 |
| 31 Mar 23 | 3,199 | 234 | 189 | 0 |
| 31 Dec 22 | 3,025 | 225 | 176 | 0 |
| 30 Sep 22 | 2,909 | 213 | 175 | 0 |
| 30 Jun 22 | 2,808 | 204 | 173 | 0 |
| 31 Mar 22 | 2,714 | 196 | 172 | 0 |
| 31 Dec 21 | 2,627 | 195 | 166 | 0 |
| 30 Sep 21 | 2,563 | 192 | 157 | 0 |
| 30 Jun 21 | 2,494 | 188 | 151 | 0 |
| 31 Mar 21 | 2,440 | 179 | 145 | 0 |
| 31 Dec 20 | 2,403 | 170 | 143 | 0 |
| 30 Sep 20 | 2,334 | 152 | 141 | 0 |
| 30 Jun 20 | 2,247 | 131 | 135 | 0 |
| 31 Mar 20 | 2,155 | 111 | 128 | 0 |
| 31 Dec 19 | 2,037 | 92 | 123 | 0 |
| 30 Sep 19 | 1,728 | 58 | 106 | 0 |
| 30 Jun 19 | 1,730 | 56 | 102 | 0 |
| 31 Mar 19 | 1,734 | 58 | 96 | 0 |
| 31 Dec 18 | 1,755 | 59 | 91 | 0 |
| 30 Sep 18 | 1,991 | 77 | 95 | 0 |
| 30 Jun 18 | 1,948 | 71 | 90 | 0 |
| 31 Mar 18 | 1,900 | 61 | 85 | 0 |
| 31 Dec 17 | 1,598 | 17 | 74 | 0 |
| 30 Sep 17 | 1,795 | 48 | 73 | 0 |
| 30 Jun 17 | 1,751 | 45 | 71 | 0 |
| 31 Mar 17 | 1,713 | 44 | 73 | 0 |
| 31 Dec 16 | 1,655 | 50 | 69 | 0 |
| 30 Sep 16 | 1,595 | 45 | 72 | 0 |
| 30 Jun 16 | 1,518 | 48 | 71 | 0 |
| 31 Mar 16 | 1,419 | 49 | 67 | 0 |
| 31 Dec 15 | 1,342 | 55 | 64 | 0 |
| 30 Sep 15 | 1,246 | 53 | 59 | 0 |
| 30 Jun 15 | 1,155 | 49 | 55 | 0 |
| 31 Mar 15 | 1,094 | 38 | 51 | 0 |
| 31 Dec 14 | 1,027 | 36 | 48 | 0 |
| 30 Sep 14 | 988 | 38 | 47 | 0 |
| 30 Jun 14 | 956 | 39 | 45 | 0 |
| 31 Mar 14 | 926 | 50 | 43 | 0 |
| 31 Dec 13 | 905 | 26 | 36 | 0 |
Kwaliteitswinsten: ENSG has high quality earnings.
Groeiende winstmarge: ENSG's current net profit margins (5.8%) are lower than last year (7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ENSG's earnings have grown by 16% per year over the past 5 years.
Versnelling van de groei: ENSG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: ENSG had negative earnings growth (-3.3%) over the past year, making it difficult to compare to the Healthcare industry average (11.4%).
Rendement op eigen vermogen
Hoge ROE: ENSG's Return on Equity (13.7%) is considered low.